Châteaugiron, France

Francois Carreaux

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université De Rennes 1. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Carreaux. Retrieved from https://idiyas.com/inventor/francois-carreaux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Francois Carreaux

Introduction

Francois Carreaux is a notable inventor based in Chateaugiron, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on imidazolone derivatives. His innovative approach has led to advancements in the preparation and biological applications of these compounds.

Latest Patents

Francois Carreaux holds a patent for "Imidazolone derivatives, method for the preparation thereof and biological applications." This patent focuses on the use of imidazolone derivatives as medicaments, showcasing his commitment to developing new therapeutic options.

Career Highlights

Throughout his career, Carreaux has been associated with prestigious institutions such as Université De Rennes 1 and the Centre National De La Recherche Scientifique. His work in these organizations has allowed him to explore various aspects of medicinal chemistry and contribute to scientific research.

Collaborations

Francois Carreaux has collaborated with esteemed colleagues, including Jean-Pierre Bazureau and Steven Renault. These partnerships have enriched his research and expanded the impact of his innovations in the field.

Conclusion

Francois Carreaux's contributions to the field of medicinal chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…